Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
about
Biochemical prevention and treatment of viral infections - a new paradigm in medicine for infectious diseasesThe use of antisense oligonucleotides in evaluating survivin as a therapeutic target for radiation sensitization in lung cancerApproved Antiviral Drugs over the Past 50 YearsVariables and strategies in development of therapeutic post-transcriptional gene silencing agentsPossibilities for RNA interference in developing hepatitis C virus therapeutics.Telomerase inhibition in cancer therapeutics: molecular-based approachesHemagglutinin-targeting Artificial MicroRNAs Expressed by Adenovirus Protect Mice From Different Clades of H5N1 InfectionTherapeutic nucleic acids: current clinical status.Antisense antimicrobial therapeuticsNonviral gene delivery system.
P2860
Q24801934-F5D9C9C5-F0EE-487A-8D60-5CAE47A15F06Q24804080-17481317-2E2E-4DE3-9D4E-A6483A86E74EQ27755387-950D579C-BEE2-484B-B508-92B77F27B5C1Q35110219-EC9D63C8-778F-459F-9F62-F35C29F27C20Q35261143-66754CF8-23EB-4613-A78A-268D1EF4E01AQ36638624-B402FAC1-BB7E-4446-A765-C9C7DDBD5526Q37238922-AC305297-8040-4886-BA6D-3E936C5BF319Q38816703-9ADC062E-8732-489D-BD73-63AE8A55FFCCQ38885150-0280E15D-D7E0-4B92-933E-63338928A446Q42214886-70A75E47-5FE6-4BD9-8A26-DD714A7AE22A
P2860
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
@ast
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
@en
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
@nl
type
label
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
@ast
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
@en
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
@nl
prefLabel
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
@ast
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
@en
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
@nl
P1476
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
@en
P2093
P304
P577
2001-06-01T00:00:00Z